Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine | SpringerLink
Ioannis Trougakos * - AD Scientific Index 2022
Genentech: Baris Bingol | Principal Scientist, Neuroscience
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment - Abstract - Europe PMC
Amazon.com: Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books
University of Athens | Tascmar
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Loop | Ioannis Trougakos
Biomedicine Archives - Page 2 of 3 - Neuro-Psychology
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books - Amazon.com
How to pronounce Ioannis P Trougakos | HowToPronounce.com
CHUNLONG CHEN | Institut Curie
Natural compounds with anti-ageing activity - Natural Product Reports (RSC Publishing) DOI:10.1039/C3NP70031C
Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram
The Speakers – ICSA 2019 Athens
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology
Home
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients - ScienceDirect
Olive Bioactives: applications and prospects | LE STUDIUM
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
